Reumatology
Tocilizumab
IV benzodiazepines (e.g, Lorazepam)
FEurea <35%
To predict in hospital mortality
Impetigus
Less than 6 mg/dl
Subarachnoid hemorrhage
>20 mL/min/1.73 m2
HBeAg antigen detection
Topical antibiotics (Mupirocin)
Double contour sign
Middle cerebral artery
CKD-EPI 2021
Vitamin E
Lymphedema
7-12 points
Evoked potentials
Membranous nephropathy
MELD-Na
Rapid progression and severe pain in necrotizing fasciitis
NLRP3
APOE 4 allele
apol 1/NPHS2
Atezolizumab plus bevacizumab
Guselkumab or Risankizumab